Atrial Fibrillation Market Research & Emerging Trends Report to 2023

Atrial fibrillation Market Size, Share, Trends, Company Profiles, Demand,

Insights, Analysis, Research, Report, Opportunities, Segmentation and

Forecast To 2023

Summary

Atrial fibrillation (AF) is a disorder of the heart's electrical system. AF is one of the most

common cardiovascular diseases among the elderly, worldwide. According to the Global Burden

of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world's

population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease

burden is likely to increase in the near future due to the projected increase in the population,

especially the elderly population.

GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will

grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to

12,316,458 diagnosed prevalent cases in 2023. GlobalData epidemiologists attribute the growth

in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in

the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these

markets.

GlobalData's epidemiological forecast for the diagnosed prevalent cases of AF in the 8MM is

supported by epidemiologic data from country-specific studies that are nationally representative

of the entire population in these markets. GlobalData's epidemiological analysis included the

most recently published nationally-representative studies in the 8MM, which provided the

diagnosed prevalence of AF using uniform diagnostic criteria based on EKG tests. Furthermore,

the diagnosed prevalent cases of AF in each of the 8MM were further segmented by age and sex

to provide a more detailed analysis of the patient population. The distribution of cases segmented

by age and sex is important for understanding the burden of AF in various subgroups of the

populations in each market, and for achieving better management of the condition....